Skip to main content
Equibles

Nantahala Capital Management, LLC

Position in DMRA — Damora Therapeutics, Inc.

CIK 1472322 New Canaan, CT
Back to DMRA Full portfolio

Position in DMRA

as of Jun 30, 2026 · filed Aug 19, 2026
Position Value
$7,230,780
+$30,580 QoQ
Shares Held
278,000
0.0% QoQ
Ownership
0.450%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#34
of 104 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DMRA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Nantahala Capital Management, LLC holds $620,287,047 across 52 Biotechnology names. DMRA ranks #31 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 SVRA
Savara Inc
 6,976,810 $42,977,149
2 AVTX
Avalo Therapeutics, Inc.
 1,862,250 $34,414,380
3 LBRX
Lb Pharmaceuticals Inc
 1,052,894 $34,171,674
4 ABEO
Abeona Therapeutics Inc.
 5,136,490 $31,743,508
5 ZVRA
Zevra Therapeutics, Inc.
 1,797,476 $25,775,805
6 MLYS
Mineralys Therapeutics, Inc.
 820,481 $22,136,577
7 QURE
uniQure N.V.
 455,660 $20,987,699
8 AURA
Aura Biosciences, Inc.
 2,951,030 $20,952,313

All Filings in DMRA

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,230,780 278,000
2026-03-31 $7,200,200 278,000